港股异动 | 赛生药业(06600)跌7% 鼎晖投资数日内减持超11%总股份

智通财经
Dec 19, 2022

智通财经APP获悉,赛生药业(06600)再度调整,午后跌超7%。自本月初短线大涨以来,赛生药业持续高位震荡。期间,公司主要机构股东相继减持。其中,鼎晖投资累计抛售超11%公司总股份。截至发稿,赛生药业跌7.66%,报8.20港元,成交额0.76亿港元。

联交所最新数据显示,12月8日、12日和15日,赛生药业第二大股东鼎晖投资三度进场减持,累计持仓占比由15.17%降至3.85%。而在12月5日,公司另一机构股东中央汇金减持赛生药业100万股,好仓占比降至11.92%。据招股书数据,2017年,由GL Capital牵头,鼎晖投资、中央汇金旗下安瀚有限公司等组成的财团对公司发起美股私有化。21年3月上市时,鼎晖投资、中央汇金持股占比分别为15.72%、12.47%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10